Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001220274 | SCV001392254 | likely benign | Episodic ataxia type 2; Developmental and epileptic encephalopathy, 42 | 2023-09-18 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002436848 | SCV002744803 | uncertain significance | Inborn genetic diseases | 2017-05-31 | criteria provided, single submitter | clinical testing | The p.R894W variant (also known as c.2680C>T), located in coding exon 19 of the CACNA1A gene, results from a C to T substitution at nucleotide position 2680. The arginine at codon 894 is replaced by tryptophan, an amino acid with dissimilar properties. This amino acid position is not well conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |